Clinical Trials Browser

Phase 3 × Surgical Procedures, Operative × Genitourinary × Clear all

NCT04700124 2026-02-05

KEYNOTE-B15

Phase 3 Completed

Parkinson Disease 4, Autosomal Dominant Lewy Body, Urinary Bladder Neoplasms

NCT03924856 2025-08-28

KEYNOTE-866

Phase 3 Active not recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Urinary Bladder Neoplasms

NCT03924895 2025-08-28

KEYNOTE-905

Phase 3 Active not recruiting

595 enrolled 1 FDA

Urinary Bladder Neoplasms

NCT05448547 2025-07-01

GrandP/SPCG19

Phase 3 Recruiting

Prostatic Neoplasms

NCT06350825 2024-04-05

Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients

Phase 3 Recruiting

Prostatic Neoplasms, Directly Observed Therapy

NCT00430183 2023-02-09

Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer

Phase 3 Active not recruiting

788 enrolled 10 charts

Prostatic Neoplasms

NCT00053352 2021-07-13

Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors

Phase 3 Completed

302 enrolled 9 charts

GenitourinaryGynecologic

Ovarian Germ Cell Cancer, Teratoma, Testicular Neoplasms, Endodermal Sinus Tumor

NCT00023686 2016-07-06

Surgery Versus Internal Radiation in Treating Patients With Stage II Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00003824 2012-03-09

S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer

Phase 3 Terminated

Urinary Bladder Neoplasms